Clinical Resources

Authored and endorsed clinical documents provide three main components vital to advancements in the heart rhythm field: analysis, discussion of current issues, and suggestions for clinical application.

HRS Clinical Document Methodology

The HRS Clinical Document Development Methodology Manual and Policies transparently declares the standards by which the HRS develops clinical practice documents, which include clinical practice guidelines, expert consensus statements, scientific statements, clinical competency statements, task force policy statements, and proceedings statements.

2012 HRS/ACCF Expert Consensus Statement on Pacemaker Device Mode Selection

Device Therapy

June 26, 2012 — The statement is the first of its kind to specifically address pacemaker device and mode selection, expanding upon the ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities.

The new statement provides a state-of-the-art review of the field and reports consensus recommendations on pacemaker device and mode selection. It is a guide to facilitate the appropriate use of single vs. dual-chamber devices for patients who already meet guidelines for pacemaker implantation.

2012 Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White

Pediatric

May 2012 — The expert consensus statement provides first-of-its-kind clinical practice guidelines on the evaluation and management of asymptomatic young patients with a WPW electrocardiographic pattern. This is also the first collaboration between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS).

2012 PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern

Pediatric

May 2012 — The expert consensus statement provides first-of-its-kind clinical practice guidelines on the evaluation and management of asymptomatic young patients with a WPW electrocardiographic pattern. This is also the first collaboration between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS).

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation

Ablation

This document has been retired and replaced by "2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation."

March 5, 2012—The purpose of the 2012 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of atrial fibrillation. It reports on the findings of a Task Force, convened by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and the European Cardiac Arrhythmia Society (ECAS) and charged with defining the indications, techniques, and outcomes of this procedure.

2011 HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

Allied Professional

August 2011—Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be lifesaving for some patients, the Heart Rhythm Society and the European Heart Rhythm Association have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

This document was reaffirmed on April 11, 2018, and will be formally assessed by April 2023.

2011 HRS Policy Statement: Clinical Cardiac Electrophysiology (CCEP) Fellowship Curriculum

Training

Endorsed by the Heart Rhythm Society in May 2011; published in the August 2011 edition of HeartRhythm Journal.

August 2011 (Update) — A fellowship curriculum is indispensable in the training of a clinical cardiac electrophysiologist. A CCEP curriculum was first published in 2001 and served as the basis for education in many fellowship programs. Over the last decade, cardiac electrophysiology continued to grow, evolve, and mature, which necessitated an update.

2011 Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors

Device Therapy

July 2011—Developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA) and the Society of Thoracic Surgeons (STS), a diverse panel of experts in pacemaker and defibrillator management focused on medical procedures that might interfere with cardiovascular implantable electronic devices (CIEDs) function.

2011 Guidance for the Heart Rhythm Society Pertaining to Interactions with Industry

Clinical EP

April 26, 2011On October 18, 2010, HRS convened the Relationships with Industry Task Force to consider whether it should continue to collaborate with industry, why collaboration may be important, and to set parameters around industry collaboration. The Task Force concluded that collaboration with industry on research and innovation is required to achieve HRS’s mission. Nevertheless, because the potential for actual or perceived bias or conflict of interest does exist, it is necessary to establish strict ethical standards to protect the credibility of HRS and its members.

2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Update on Dabigatran/2006 Guideline)

Atrial Arrhythmias

This document has been retired and replaced by "2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation."

February 14, 2011—This guideline update states that dabigatran, a new antithrombotic agent that was recently approved by the U.S. Food and Drug Administration, is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation. The update is a joint publication of the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), and the Heart Rhythm Society (HRS).